Lea S Eiland

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Emergency Department

Respiratory Syncytial Virus

Ejection Fraction

Top Venues

The Annals of pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

James Hunter Fly, Lea S Eiland, Jeremy S Stultz
Nirsevimab: Expansion of Respiratory Syncytial Virus Prevention Options in Neonates, Infants, and At-Risk Young Children. The Annals of pharmacotherapy (2024)
Jeremy S Stultz, Lea S Eiland
A Review of the Data Supporting Use of COVID-19 Vaccinations in the Pediatric Population. The Annals of pharmacotherapy (2023)
Lea S Eiland, John Brock Harris, Amy P Holmes
Considerations for Treating Nonobstetric Diseases in Pregnant Patients in the Emergency Department Setting. The Annals of pharmacotherapy (2023)
Jeremy S Stultz, Lea S Eiland
A Review of the Data Supporting Use of COVID-19 Vaccinations in the Pediatric Population. The Annals of pharmacotherapy (2023)
John Brock Harris, Amy P Holmes, Lea S Eiland
The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources. The Annals of pharmacotherapy 55 (4) (2020)
Jeremy S Stultz, Lea S Eiland
Doxycycline and Tooth Discoloration in Children: Changing of Recommendations Based on Evidence of Safety. The Annals of pharmacotherapy 53 (11) (2019)
Hana Rac Winders, Alyssa P Gould, Lea S Eiland, Brooke Griffin, Milena McLaughlin, Kayla R Stover, Christopher M Bland, Paul Brandon Bookstaver
Common Bacterial and Viral Infections: Review of Management in the Pregnant Patient. The Annals of pharmacotherapy 53 (6) (2018)
Christopher Wren, Edward Bell, Lea S Eiland
Ozenoxacin: A Novel Topical Quinolone for Impetigo. The Annals of pharmacotherapy 52 (12) (2018)